Lana K Hochmuth

发表

Stable Ischemic Heart Disease

Lana K Hochmuth, 2017 .

Durvalumab: a newly approved checkpoint inhibitor for the treatment of urothelial carcinoma.

K. Bauer, R. Deshmukh, Stephanie M. Wills, 2019, Current problems in cancer.